Biosyngen Best-in-Class Next-Generation Tumor-Infiltrating Lymphocyte (TIL) Technology Debuts at ESMO 2024 Annual Meeting.
BARCELONA, Spain, September 20, 2024 /PRNewswire/ — Highly anticipated 2024 European Society for Medical Oncology (ESMO) Annual Congress took place […]